We are live on
!
Find out more
FA
Fagan Associates Portfolio holdings
AUM
$719M
1-Year Est. Return
26.65%
This Fund
S&P 500
This Quarter
Est. Return
+1.45%
1 Year Est. Return
+26.65%
3 Year Est. Return
+87.69%
5 Year Est. Return
+107.31%
10 Year Est. Return
+467.14%
AUM
$122M
AUM Growth
+$4.83M
(+4.1%)
Cap. Flow
+$4.26M
Cap. Flow
% of AUM
3.5%
Top 10 Holdings %
Top 10 Hldgs %
38.79%
Holding
96
New
11
Increased
38
Reduced
29
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Herc Holdings
HRI
|
+$2.41M |
| 2 |
D.R. Horton
DHI
|
+$972K |
| 3 |
Hain Celestial
HAIN
|
+$920K |
| 4 |
First Solar
FSLR
|
+$915K |
| 5 |
DuPont de Nemours
DD
|
+$888K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.18M |
| 2 |
Ford
F
|
+$983K |
| 3 |
GE Aerospace
GE
|
+$908K |
| 4 |
FWLT
FOSTER WHEELER AG (SWITZERLAND)
FWLT
|
+$807K |
| 5 |
SAVE
Spirit Airlines, Inc.
SAVE
|
+$680K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.75% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Industrials | 9.79% |
| 4 | Energy | 9.31% |
| 5 | Healthcare | 9.21% |
Similar funds
EI
SAM
KC
TFA
WRPWM
WLIM
NI
CFO
Fagan Associates's Q3 2014 Portfolio in Review
As of Q3 2014, Fagan Associates held 96 positions worth $122M, up 4.1% from $117M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Fagan Associates deployed $4.26M of net new capital in Q3 2014, opening 11 new positions and adding to 38 existing holdings. Its largest new stake was Herc Holdings: 28,222 shares worth $2.15M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Ford, an estimated $983K trimmed.
- Fagan Associates's largest Q3 2014 buy was Herc Holdings: 28,222 shares worth $2.15M.
- Fagan Associates added most to D.R. Horton in Q3 2014, an estimated $972K increase.
- Fagan Associates's biggest Q3 2014 reduction was Ford, cutting an estimated $983K.
- Fagan Associates fully exited Pfizer in Q3 2014, selling an estimated $1.18M.
- Fagan Associates's ten largest holdings make up 39% of its $122M portfolio in Q3 2014.
- Fagan Associates opened 11 new positions and closed 11 in Q3 2014.
- Fagan Associates's portfolio value rose 4.1% quarter-over-quarter to $122M.
Based on Fagan Associates's 13F filing for Q3 2014, filed 12 Nov 2014.